Enter your login e-mail to the account
Search
Search parameters
Search results
- Weight loss pharmacotherapy of obese non-diabetic and type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(6/2015, Topic of the year ) - ACROMEGALY – DIAGNOSTICALLY UNDERESTIMATED DISEASE
doc. MUDr. Ján Podoba, CSc., MUDr. Ľudmila Trejbalová
(7-8/2008, clearly )
- Functional recovery as an achievable goal of the treatment of depression
Mgr. MUDr. Jozef Dragašek, PhD., MHA, MUDr. Slávka Dubinská, MHA, MUDr. Zuzana Vančová, PhD.
(S3/2022, Supplement ) - Nové trendy v léčbě obsedantně kompulzivní poruchy
MUDr. Pavla Stopková, Ph.D.
(2/2018, Review articles ) - Treatment of bipolar disorder: manic and mixed episodes, rapid cycling
MUDr. Ľubica Forgáčová, PhD.
(4/2009, Review articles ) - Antipsychotics in the treatment of predominant negative symptoms in schizophrenia - What are the updated guidelines telling us?
MUDr. Zuzana Vančová, PhD., Mgr. MUDr. Jozef Dragašek, PhD., MHA
(4/2020, Psychopharmacology )
- Treatment of multiple sclerosis with first-line therapy and prenancy
MUDr. Mgr. Matouš Rous, MUDr. Zuzana Rous, Ph.D.
(1/2020, Case reports ) - Immunological outlook on modern therapy of multiple sclerosis
doc. MUDr. Vojtěch Thon, Ph.D.
(5/2016, From the boundary of neurology ) - NEDA-4 concept as a treatment outcome in multiple sclerosis patients
MUDr. Pavel Hradílek, Ph.D.
(3/2016, Review articles ) - Painful diabetic neuropathy
prof. MUDr. Zdeněk Ambler, DrSc.
(1/2012, Review articles ) - New treatment options for pediatric patients with multiple sclerosis
doc. MUDr. Jarmila Szilasiová, PhD.
(3/2019, Review articles ) - Multifocal motor neuropathy
doc. MUDr. Peter Špalek, PhD.
(1/2016, Main topic ) - Aubagio (teriflunomid) jako jedna z možností léčby u mužů s roztroušenou sklerózou
MUDr. Zuzana Matejčíková
(1/2017, Case reports )
- The current treatment options for epilepsy
doc. MUDr. Pavol Sýkora, CSc., MUDr. Lucia Švecová
(3/2014, Review articles ) - The most frequent skin diseases in childhood and their therapy
MUDr. Štěpánka Čapková
(1/2009, Review articles )
- New treatment options in hormone-sensitive prostate cancer
MUDr. Otakar Čapoun, Ph.D., FEBU
(5/2019, Review articles ) - Management of treatment-related adverse effects in renal cell carcinoma
MUDr. Martin Matějů, Ph.D., MUDr. Michal Zubaľ
(1/2024, From the frontier of urology ) - Current position of chemotherapy in treating bladder cancer
MUDr. Jana Katolická, Ph.D.
(2/2016, Review articles )
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - Publikujeme v zahraničí
(6/2014, Information & comments ) - Treatment options in multiple myeloma
prof. MUDr. Elena Tóthová, CSc.
(1/2007, Review articles ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - Treatment of localised and advanced diffuse large B-cell lymphoma
MUDr. Veronika Ballová
(3/2015, Spectrum ) - Systemic treatment of local advanced non resekability or metastatic urothelial carcinoma
MUDr. Jana Obertová, PhD.
(2/2021, Review articles ) - Gastrointestinal stromal tumors and some new treatment options
MUDr. Iveta Andrezálová Vochyanová
(3/2015, Review articles ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Contemporary possibilities of adrenocortical carcinoma treatment
doc. MUDr. Ján Ľupták, PhD., prof. MUDr. Ján Kliment, CSc., MUDr. Boris Eliáš, PhD., prof. MUDr. Ján Švihra, PhD., MUDr. Ján Kliment jr.
(1/2013, Review articles ) - Effective treatment of lung adenocarcinoma with target therapy – case report
MUDr. Gabriela Chowaniecová
(5/2017, Original articles & case reports ) - New trends in the treatment of non-small cell renal cell carcinoma
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(4/2022, Main topic ) - Review on castrate-resistant prostate carcinoma systemic therapy
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2023, Main topic ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - The present approach to treatment of renall cell carcinoma
MUDr. Zuzana Syčová-Milá
(5/2010, Review articles ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - Treatment of metastatic clear cell renal cell carcinoma after failure of first-line treatment
MUDr. Marián Streško, PhD.
(4/2014, Main topic ) - Advanced urothelial carcinoma systemic treatment in the light of immunotherapy
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA
(3/2017, Review articles ) - Current options and strategies for choosing treatment for metastatic colorectal cancer after first-line failure
MUDr. Juraj Beniak
(6/2020, Review articles ) - Optimal first line treatment in advanced/metastatic renal carcinoma-immunotherapy, targeted therapy, combinations
MUDr. Katarína Rejleková, PhD.
(6/2020, Review articles ) - Publikujeme v zahraničí
(1/2015, Information & comments ) - FLT3mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby
MUDr. Eva Mikušková, PhD., RNDr. Renata Lukačková, RNDr. Imrich Hikkel, PhD., Mgr. Michaela Zrubcová
(3/2018, Original articles & case reports ) - Biological therapy in colorectal cancer
MUDr. Jozef Dolinský
(2/2011, Review articles ) - Treatment alternatives in newly diagnosed patients with chronic myeloid leukemia
MUDr. Zuzana Sninská, PhD.
(3/2012, Topic of the year ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles ) - Large B-cell lymphomas – paradigm 2024
MUDr. Tomáš Guman, PhD., MBA, MUDr. Ján Sýkora
(1/2024, Main topic ) - Publikujeme v zahraničí
(5/2015, Information & comments ) - Decision-making algorithm in the therapy of patients with advanced malignant melanoma
MUDr. Silvia Jurišová, PhD.
(1/2024, Review articles ) - First administration of caplacizumab in first-line treatment for acquired acute thrombotic thrombocytopenic purpura – casuistry
MUDr. Renáta Pizurová, MUDr. Pavol Hollý, PhD., MUDr. Tomáš Šimurda, PhD., MUDr. Juraj Chudej, PhD., MBA, doc. MUDr. Juraj Sokol., PhD., MBA, MUDr. Kristína Mária Beláková, Prof. MUDr. Ján Staško, PhD., MUDr. Ján Hudeček, PhD., Ing. Ingrid Škorňová, PhD., MUDr. Alena Ježíková
(S1/2024, Case reports ) - Faslodex 500 and new treatment options
MUDr. Katarína Petráková
(6/2010, Drugs & drug classes ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Current treatment trends for multiple myeloma – subcutaneous administration of proteasome inhibitor
MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Janka Baňáková, MUDr. Hilda Šajgalíková, MUDr. Miroslav Šimek, PhD.
(2/2014, Review articles ) - Management of chronic myeloid leukemia after failure of second generation tyrosine kinase inhibitors
MUDr. Katarína Slezáková, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Peter Rohoň, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2022, Review articles ) - Nivolumab in the renal cell carcinoma treatment
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA, LL.M., Vladimíra Baranová
(1/2018, Main topic ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic ) - Glukokortikoidy v liečbe kastračne-rezistentného karcinómu prostaty a mechanizmy rezistencie na androgénnu blokádu
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2018, Review articles ) - Systemic treatment of advanced pancreatic cancer and the role of nanoliposomal irinotecan in it
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(3/2023, Main topic )
- The most frequent skin diseases in childhood and their therapy
MUDr. Štěpánka Čapková
(3/2010, Review articles ) - Gonorrhoea in Slovakia – case analysis of infections caused by Neisseria gonorrhoeae and resistance review in 2012
RNDr. Peter Pavlík
(2-3/2013, Review articles )
- ACE – INHIBITORS AND AT1R – ANTAGONISTS ARE THE FIRST LINE MEDICATION FOR IgA NEPHROPATHY
prof. MUDr. Karel Matoušovic, DrSc.
(2/2008, Drug classes )
- Macular degeneration – herbal therapy and prevention
PharmDr. Silvia Fialová, PhD.
(3/2012, Phytotherapy ) - Use of over-the-counter medications in pregnancy
PharmDr. Anna Oleárová, PhD., MPH, MUDr. Anna Poizlová
(2/2016, Clinical pharmacy ) - Use of over-the-counter medications in lactation
PharmDr. Anna Oleárová, PhD., MPH, MUDr. PharmDr. Zuzana Javorová-Rihová
(4/2016, Clinical pharmacy )
- Current status and perspectives of pharmacotherapy of pulmonary arterial hypertension
MUDr. Pavel Jansa
(3/2011, Review articles )